melanotan for sleep Melatonin: Should You Stop Taking It? Melatonin: A potential nighttime guardian

Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial

Peptide-protein conjugates combine the targeting ability of peptides with the extended half-life of proteins, potentially reducing dosing frequency while maintaining therapeutic effectiveness

Antioxidants neutralize free radicals that can accelerate follicular senescence

Compounded medications are not evaluated or approved by the FDA for safety, efficacy or quality Healthcare leaders are closely monitoring the peptide regulatory approval pathways